Therapy restores lost memory in Alzheimer's model

A team of researchers at MIT has discovered that a combination of mental stimulation and histone deacetylase, or HDAC, inhibitors can restore lost memories in mice engineered to develop Alzheimer's. Most of the new therapies in development for Alzheimer's are targeting the early stage of the disease. But these researchers found that even after Alzheimer's has caused severe memory loss, the therapeutic combination could be effective in helping restore learning and memory. The British journal Nature published their findings.

- read the report from the BBC

ALSO: Over-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's disease, according to new research. Release

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.